Back to Trades
Sell4
ENvue Medical, Inc.
FEED
Total Value
$8.9K
Net $8.9K sold
Sales
$8.9K
30 transactions
Company Information
- Company Name
- ENvue Medical, Inc.
- Ticker Symbol
- FEED
- CIK
- 0001326706
Insider Information
- Role
- 10% Owner
- Location
- CHARLOTTE, NC
10% Owner
Filing Details
- Filing Date
- Feb 4, 2026
- Transaction Date
- Feb 2, 2026
- Accession Number
- 0000070858-26-000030
- Form Type
- 4
- Net Trading Amount
- -$8.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | 100 | $3.05 | Sale | $305 |
| Feb 2, 2026 | Common Stock | 10 | $3.05 | Sale | $31 |
| Feb 2, 2026 | Common Stock | 4 | $3.05 | Sale | $12 |
| Feb 2, 2026 | Common Stock | 4 | $3.05 | Sale | $12 |
| Feb 2, 2026 | Common Stock | 100 | $3.04 | Sale | $304 |
| Feb 2, 2026 | Common Stock | 200 | $3.06 | Sale | $612 |
| Feb 2, 2026 | Common Stock | 500 | $3.05 | Sale | $1.5K |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 18 | $3.05 | Sale | $55 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 100 | $3.05 | Sale | $305 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 100 | $3.05 | Sale | $305 |
| Feb 2, 2026 | Common Stock | 100 | $3.05 | Sale | $305 |
| Feb 2, 2026 | Common Stock | 183 | $3.05 | Sale | $558 |
| Feb 2, 2026 | Common Stock | 2 | $3.05 | Sale | $6 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 417 | $3.05 | Sale | $1.3K |
| Feb 2, 2026 | Common Stock | 98 | $3.05 | Sale | $299 |
| Feb 2, 2026 | Common Stock | 82 | $3.05 | Sale | $250 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 100 | $3.06 | Sale | $306 |
| Feb 2, 2026 | Common Stock | 50 | $3.05 | Sale | $153 |
| Feb 2, 2026 | Common Stock | 100 | $3.07 | Sale | $307 |
| Feb 2, 2026 | Common Stock | 90 | $3.05 | Sale | $275 |
| Feb 2, 2026 | Common Stock | 10 | $3.05 | Sale | $31 |
| Feb 2, 2026 | Common Stock | 100 | $3.07 | Sale | $307 |
| Feb 2, 2026 | Common Stock | 100 | $3.05 | Sale | $305 |
Footnotes
- (F1)This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.
- (F2)Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
- (F3)Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.